Star power: harnessing the reactive astrocyte response to promote remyelination in multiple sclerosis
Authors:
Open Access
- 20 July 2023
- journal article
- review article
- Published by Medknow in Neural Regeneration Research
- Vol. 19 (3) , 578-582
Abstract
Astrocytes are indispensable for central nervous system development and homeostasis. In response to injury and disease, astrocytes are integral to the immunological- and the, albeit limited, repair response. In this review, we will examine some of the functions reactive astrocytes play in the context of multiple sclerosis and related animal models. We will consider the heterogeneity or plasticity of astrocytes and the mechanisms by which they promote or mitigate demyelination. Finally, we will discuss a set of biomedical strategies that can stimulate astrocytes in their promyelinating response.Keywords
This publication has 93 references indexed in Scilit:
- Glial Scar Borders Are Formed by Newly Proliferated, Elongated Astrocytes That Interact to Corral Inflammatory and Fibrotic Cells via STAT3-Dependent Mechanisms after Spinal Cord InjuryThe Journal of Neuroscience, 2013
- Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic networksNucleic Acids Research, 2012
- Genomic Analysis of Reactive AstrogliosisThe Journal of Neuroscience, 2012
- Neuroprotection mediated through estrogen receptor-α in astrocytesProceedings of the National Academy of Sciences, 2011
- Astrocytic Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Promotes Oligodendrocyte Differentiation and Enhances CNS MyelinationJournal of Neuroscience, 2011
- CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone modelMolecular Immunology, 2010
- Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease durationBrain, 2010
- Oxidative stress disrupts oligodendrocyte maturationJournal of Neuroscience Research, 2009
- STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord InjuryThe Journal of Neuroscience, 2008
- Persistent Macrophage/Microglial Activation and Myelin Disruption after Experimental Autoimmune Encephalomyelitis in Tissue Inhibitor of Metalloproteinase-1-Deficient MiceThe American Journal of Pathology, 2006